This prospective study aimed to evaluate the roles of GSTM1, GSTT1, and GSTP1 Ile105Val polymorphisms in outcomes of HNSCC patients treated with CDDP chemoradiation. The gene discussed is GSTP1; the disease is head and neck squamous cell carcinoma.